Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

1.

The transmembrane protein-tyrosine phosphatase CD45 is associated with decreased insulin receptor signaling.

Kulas DT, Freund GG, Mooney RA.

J Biol Chem. 1996 Jan 12;271(2):755-60.

PMID:
8557683
[PubMed - indexed for MEDLINE]
Free Article
2.

The transmembrane protein-tyrosine phosphatase LAR modulates signaling by multiple receptor tyrosine kinases.

Kulas DT, Goldstein BJ, Mooney RA.

J Biol Chem. 1996 Jan 12;271(2):748-54.

PMID:
8557682
[PubMed - indexed for MEDLINE]
Free Article
3.
4.

Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells.

Li PM, Zhang WR, Goldstein BJ.

Cell Signal. 1996 Nov;8(7):467-73. Review.

PMID:
9023010
[PubMed - indexed for MEDLINE]
5.

Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation.

Harada S, Smith RM, Smith JA, White MF, Jarett L.

J Biol Chem. 1996 Nov 22;271(47):30222-6. Erratum in: J Biol Chem 1997 Jan 31;272(5):3124.

PMID:
8939974
[PubMed - indexed for MEDLINE]
Free Article
6.
7.

Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.

Mur C, Valverde AM, Kahn CR, Benito M.

Diabetes. 2002 Mar;51(3):743-54.

PMID:
11872675
[PubMed - indexed for MEDLINE]
Free Article
8.

Functional importance of Shc tyrosine 317 on insulin signaling in Rat1 fibroblasts expressing insulin receptors.

Ishihara H, Sasaoka T, Ishiki M, Takata Y, Imamura T, Usui I, Langlois WJ, Sawa T, Kobayashi M.

J Biol Chem. 1997 Apr 4;272(14):9581-6.

PMID:
9083103
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Dissociation of PTPase levels from their modulation of insulin receptor signal transduction.

Bleyle LA, Peng Y, Ellis C, Mooney RA.

Cell Signal. 1999 Oct;11(10):719-25.

PMID:
10574326
[PubMed - indexed for MEDLINE]
11.

Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways.

Sorokin A, Reed E, Nnkemere N, Dulin NO, Schlessinger J.

Oncogene. 1998 May 14;16(19):2425-34.

PMID:
9627109
[PubMed - indexed for MEDLINE]
Free Article
12.
13.

Expression of dominant negative mutant SHPTP2 attenuates phosphatidylinositol 3'-kinase activity via modulation of phosphorylation of insulin receptor substrate-1.

Ugi S, Maegawa H, Kashiwagi A, Adachi M, Olefsky JM, Kikkawa R.

J Biol Chem. 1996 May 24;271(21):12595-602.

PMID:
8647870
[PubMed - indexed for MEDLINE]
Free Article
14.

Insulin receptor signaling is augmented by antisense inhibition of the protein tyrosine phosphatase LAR.

Kulas DT, Zhang WR, Goldstein BJ, Furlanetto RW, Mooney RA.

J Biol Chem. 1995 Feb 10;270(6):2435-8.

PMID:
7852302
[PubMed - indexed for MEDLINE]
Free Article
15.

Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase.

De Fea K, Roth RA.

J Biol Chem. 1997 Dec 12;272(50):31400-6.

PMID:
9395471
[PubMed - indexed for MEDLINE]
Free Article
16.

Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control.

Parpal S, Karlsson M, Thorn H, Strålfors P.

J Biol Chem. 2001 Mar 30;276(13):9670-8. Epub 2000 Dec 19.

PMID:
11121405
[PubMed - indexed for MEDLINE]
Free Article
17.

Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.

Guvakova MA, Surmacz E.

Cancer Res. 1997 Jul 1;57(13):2606-10.

PMID:
9205064
[PubMed - indexed for MEDLINE]
Free Article
19.

Cell density-dependent changes in the insulin action pathway: evidence for involvement of protein-tyrosine phosphatases.

Li PM, Goldstein BJ.

J Cell Biochem. 1996 Apr;61(1):31-8.

PMID:
8726353
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk